Results
187
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
187 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
WAL | US$84.19 | -0.8% | 90.9% | US$9.3b | US$92.75 | PB1.5x | E21.6% | 1.8% | Banks | ||
TENB | US$39.70 | 0.2% | -10.1% | US$4.7b | US$51.26 | PS5.5x | E66.6% | n/a | Software | ||
ENPH | US$113.29 | -5.4% | -5.7% | US$15.8b | US$128.00 | PE118.4x | E39.0% | n/a | Semiconductors | ||
KBR | US$64.45 | 3.7% | 8.9% | US$8.6b | US$77.50 | PE43.3x | E26.8% | 0.9% | Commercial Services | ||
FLNC | US$21.62 | -0.4% | -2.8% | US$4.0b | US$27.37 | PS1.3x | E53.3% | n/a | Capital Goods | ||
VSTA | US$2.61 | -0.8% | -37.0% | US$209.0m | US$2.92 | PB0.3x | E90.8% | n/a | Consumer Services | ||
DOX | US$85.90 | -0.4% | 0.6% | US$9.9b | US$98.98 | PE19.3x | E24.1% | 2.2% | Software | ||
PAHC | US$22.07 | -0.4% | 73.0% | US$892.7m | US$15.60 | PE370x | E51.5% | 2.2% | Pharmaceuticals & Biotech | ||
FSLR | US$241.72 | -0.04% | 52.4% | US$26.2b | US$285.23 | PE21.5x | E27.0% | n/a | Semiconductors | ||
CXT | US$55.40 | -5.0% | -0.2% | US$3.4b | US$80.80 | PE17.5x | E21.9% | 1.2% | Tech | ||
SHLS | US$5.68 | -9.6% | -71.1% | US$1.1b | US$8.86 | PE40.6x | E28.7% | n/a | Capital Goods | ||
NOAH | US$10.17 | 14.8% | -15.9% | US$658.8m | US$13.44 | PE6.9x | E20.6% | 10.8% | Diversified Financials | ||
CADE | US$31.10 | -2.9% | 48.2% | US$5.7b | US$35.50 | PB1.1x | E73.6% | 3.2% | Banks | ||
AVBH | US$19.75 | 0.05% | -7.4% | US$155.6m | US$23.50 | PB0.9x | E22.3% | n/a | Banks | ||
EVER | US$20.98 | -5.8% | 205.4% | US$752.2m | US$33.84 | PS2.3x | E61.3% | n/a | Media | ||
ENV | US$62.49 | -0.02% | 39.9% | US$3.5b | US$64.25 | PS2.6x | E71.5% | n/a | Software | ||
PFIS | US$46.10 | -4.2% | 5.3% | US$466.4m | US$49.00 | PB1.3x | E103.3% | 5.4% | Banks | ||
ALNY | US$272.73 | -0.2% | 54.2% | US$34.8b | US$285.91 | PS14.9x | E65.2% | n/a | Pharmaceuticals & Biotech | ||
SIMO | US$57.09 | 3.4% | 13.6% | US$1.9b | US$86.89 | PE24.5x | E32.4% | 3.5% | Semiconductors | ||
STKL | US$6.72 | 0.6% | 94.8% | US$797.8m | US$9.83 | PS1.2x | E159.6% | n/a | Food, Beverage & Tobacco | ||
EQT | US$35.16 | 4.9% | -11.2% | US$21.2b | US$40.38 | PE30x | E40.7% | 1.8% | Energy | ||
WEX | US$204.63 | 1.1% | 5.3% | US$8.6b | US$222.08 | PE34.2x | E31.3% | n/a | Diversified Financials | ||
CDXC | US$3.78 | 6.5% | 160.7% | US$287.7m | US$6.54 | PS3.4x | E102.9% | n/a | Pharmaceuticals & Biotech | ||
OC | US$170.31 | -1.2% | 25.3% | US$15.2b | US$186.68 | PE14.1x | E16.2% | 1.4% | Capital Goods |